Buys | $14,999,998 | 1 | 100 |
Sells | $0 | 0 | 0 |
Nippon Shinyaku Co Ltd | 10 percent owner | 1 | $15M | 0 | $0 | $15M |
Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of spectrum of diseases and disorders. Its lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has completed phase III clinical trial for the treatment of patients with late-stage Duchenne muscular dystrophy (DMD); and CAP-1002, which is in Phase II clinical trial for the treatment of cytokine storm associated with SARS-CoV-2. The company …
Over the last 12 months, insiders at Capricor Therapeutics, Inc. have bought $15M and sold $0 worth of Capricor Therapeutics, Inc. stock.
On average, over the past 5 years, insiders at Capricor Therapeutics, Inc. have bought $5.02M and sold $474.71M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Nippon Shinyaku Co Ltd (10 percent owner) — $15M.
The last purchase of 2,798,507 shares for transaction amount of $15M was made by Nippon Shinyaku Co Ltd (10 percent owner) on 2024‑09‑20.
2024-09-20 | Nippon Shinyaku Co Ltd | 10 percent owner | 2.8M 9.1284% | $5.36 | $15M | +195.20% | ||
2023-10-12 | Musket David B | director | 410 0.0015% | $2.75 | $1,128 | +63.96% | ||
2023-10-10 | COLLIER EARL M JR | director | 10,000 0.0395% | $2.83 | $28,300 | +62.63% | ||
2023-10-09 | Musket David B | director | 5,083 0.02% | $2.82 | $14,334 | +66.01% | ||
2023-10-06 | Auwaerter Paul Gisbert | director | 5,000 0.019% | $2.84 | $14,200 | +58.45% | ||
2023-10-04 | Musket David B | director | 2,500 0.0095% | $2.90 | $7,250 | +61.62% | ||
2023-04-17 | Sale | Avat Xavier | 14,772 – | $64,258.00 | $949.22M | +3.61% | ||
2023-03-28 | Sale | Avat Xavier | 3,000 0.0118% | $4.06 | $12,180 | +6.46% | ||
2022-06-29 | Sale | Musket David B | 28,215 0.1163% | $3.77 | $106,371 | +19.68% | ||
2022-06-29 | Avat Xavier | CHIEF BUSINESS OFFICER | 1,500 0.0062% | $3.76 | $5,643 | +19.68% | ||
2022-06-27 | Sale | Musket David B | 17,775 0.0736% | $4.44 | $78,921 | +1.59% | ||
2017-05-09 | CEDARS SINAI MEDICAL CENTER | 10 percent owner | 2.29M 11.0606% | $3.10 | $7.1M | -46.21% | ||
2017-05-09 | Manzo Louis | director | 20,000 0.0966% | $3.10 | $62,000 | -46.21% | ||
2017-05-09 | Musket David B | director | 50,000 0.2415% | $3.10 | $155,000 | -46.21% | ||
2016-09-21 | CEDARS SINAI MEDICAL CENTER | 10 percent owner | 625,000 3.0673% | $3.20 | $2M | -26.89% | ||
2016-03-16 | CEDARS SINAI MEDICAL CENTER | 10 percent owner | 833,332 4.8375% | $2.40 | $2M | +29.40% | ||
2016-03-16 | GRASMICK LOUIS J | director | 182,738 1.0608% | $2.40 | $438,571 | +29.40% | ||
2016-03-16 | St. John Edward A. | 10 percent owner | 833,332 4.8375% | $2.40 | $2M | +29.40% | ||
2016-03-16 | Marban Linda | Chief Executive Officer | 30,456 0.1768% | $2.40 | $73,094 | +29.40% | ||
2016-03-16 | Manzo Louis | director | 200,000 1.161% | $2.40 | $480,000 | +29.40% |
Nippon Shinyaku Co Ltd | 10 percent owner | 7090351 15.5935% | $86.64M | 1 | 0 | |
CEDARS SINAI MEDICAL CENTER | 10 percent owner | 4049959 8.9069% | $49.49M | 4 | 0 | +25.52% |
Marban Eduardo | 10 percent owner | 3173354 6.979% | $38.78M | 2 | 0 | <0.0001% |
KASH PETER M | director | 1596208 3.5105% | $19.51M | 3 | 0 | |
TANEN DAVID M | director | 1520705 3.3444% | $18.58M | 4 | 0 |
$36,510,315 | 95 | 8.95% | $611.9M | |
$587,109,125 | 90 | 3.17% | $524.24M | |
$14,527,743 | 76 | 38.40% | $495.98M | |
$678,065,999 | 37 | -13.32% | $608.58M | |
$94,912,877 | 34 | -7.15% | $601.56M |
Increased Positions | 85 | +119.72% | 11M | +133.35% |
Decreased Positions | 32 | -45.07% | 2M | -21.85% |
New Positions | 51 | New | 5M | New |
Sold Out Positions | 17 | Sold Out | 1M | Sold Out |
Total Postitions | 124 | +74.65% | 17M | +111.5% |
Blackrock, Inc. | $39,252.00 | 6.59% | 2.97M | +1M | +69.54% | 2024-12-31 |
Vanguard Group Inc | $30,122.00 | 5.06% | 2.28M | +700,243 | +44.42% | 2024-12-31 |
Farallon Capital Management Llc | $29,773.00 | 5% | 2.25M | +2M | New | 2024-12-31 |
State Street Corp | $29,217.00 | 4.91% | 2.21M | +2M | +331.06% | 2024-12-31 |
Geode Capital Management, Llc | $11,635.00 | 1.95% | 879,468 | +241,279 | +37.81% | 2024-12-31 |
Altium Capital Management Llc | $9,446.00 | 1.59% | 714,000 | +429,000 | +150.53% | 2024-12-31 |
Morgan Stanley | $8,358.00 | 1.4% | 631,754 | +500,238 | +380.36% | 2024-12-31 |
Woodline Partners Lp | $8,334.00 | 1.4% | 629,934 | +629,934 | New | 2024-12-31 |
Northern Trust Corp | $5,082.00 | 0.85% | 384,157 | +116,086 | +43.3% | 2024-12-31 |
Goldman Sachs Group Inc | $3,900.00 | 0.66% | 294,768 | +216,504 | +276.63% | 2024-12-31 |